Global mRNA Vaccines and Therapeutics Market Research Report: Forecast (2021-2026)

By mRNA Type (Nucleoside-Modified mRNA (modRNA), Unmodified mRNA, Self-Amplifying mRNA), By Application Type (COVID mRNA Application [Commercialised Vaccine {mRNA-1273, BNT162b2},......Pipeline Vaccines {CVnCoV, LUNAR-COV19, MRT5500, DS-5670}] Non-COVID mRNA Application [Immuno-Oncology, Cardiology, Endocrinology, Haematology, Other infectious & rare diseases]), By End-User (Hospitals & healthcare Clinics, Research Organisation & Institutions, Others), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa), By Country (U.S, Canada, Brazil, Argentina, Mexico, Germany, France, The U.K, Spain, Italy, China, India, Japan, Australia, South Korea, Saudi Arabia, UAE, South Africa), By Competitors (Arcturus Therapeutics Holdings Inc., BioNTech, CureVac N.V., ethris GmbH, Gennova Biopharmaceuticals Ltd, GlaxoSmithKline plc, Moderna, Pantherna Therapeutics GmbH, Pfizer, Providence Therapeutics, Providence Therapeutics, Silence Therapeutics, Translate Bio, Versameb AG, Verve Therapeutics, Inc.) Read more

  • Healthcare
  • Jul 2021
  • 232
  • PDF, Excel, PPT

Messenger Ribonucleic Acid, also called mRNA vaccine, is a single protein-coding gene in the genome that works as a basis for protein synthesis inside the cells. mRNA vaccines don't consist of the live virus and, instead, they teach cells to make a protein to initiate an immune response.

The “Global mRNA Vaccines and Therapeutics Market” is likely to grow at a CAGR of around 13% during the forecast period, i.e., 2021-26, says MarkNtel Advisors. The market growth essentially attributes to the rising prevalence of infectious and chronic diseases, including HIV, diabetes, cancer, and cardiovascular diseases.

Additionally, the inability of the traditional vaccine approaches to perform at a critical time boosts the market growth. Further, technological advancements support the growth of the market as mRNA vaccines and therapeutics are developed with the help of advanced technologies so that these vaccines are highly effective in crucial times.

The research report, “Global mRNA Vaccines and Therapeutics Market Analysis, 2021,” depicts a deep-dive market analysis of market statistics. It primarily consists of regional & country-wise market size, market forecast, CAGR & share of different market segments, competitive benchmarking, and key market drivers & restraints.

Report Coverage Details
Study Period Historical Data: 2016-19
Base Year: 2020
Forecast Period: 2021-26
CAGR (2021-2026) 13%
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy
Asia-Pacific: China, India, Japan, South Korea, Australia
South America: Brazil, and Argentina
Middle East & Africa:  UAE, Saudi Arabia, South Africa
Key Companies Profiled Arcturus Therapeutics Holdings Inc., BioNTech, CureVac N.V., ethris GmbH, Gennova Biopharmaceuticals Ltd, GlaxoSmithKline plc, Moderna, Pantherna Therapeutics GmbH, Pfizer, Providence Therapeutics, Providence Therapeutics, Silence Therapeutics, Translate Bio, Versameb AG, Verve Therapeutics, Inc.
Unit Denominations USD Million/Billion

 

COVID-19 pandemic Positively Impacted the Global mRNA Vaccines and Therapeutics Market

The COVID-19 pandemic has positively influenced the growth of the Global mRNA Vaccines and Therapeutics Market owing to the increasing number of COVID-19 patients globally and the massive external funding for the production of mRNA-based COVID-19 vaccines. Additionally, with the emergence of new variants of the SARS-COVID-19 virus across different countries worldwide, the demand for mRNA vaccines is significantly increasing as it is highly effective against new strains. However, as the impact of the COVID-19 pandemic declines in the next few years, the market for mRNA vaccines will drop, which is very likely to affect the overall market growth in the years to come.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
    4. Market Segmentation
  2. Executive Summary
  3. Impact of COVID-19 on Global mRNA Vaccines and Therapeutics Market
  4. Global mRNA Vaccines and Therapeutics Market Analysis Trends & Insights
  5. Global mRNA Vaccines and Therapeutics Market Intellectual Property Rights Analysis
  6. Global mRNA Vaccines and Therapeutics Market Analysis Hotspots & Opportunities
  7. Global mRNA Vaccines and Therapeutics Market Analysis Government Regulations
  8. Global mRNA Vaccines and Therapeutics Market Use Case Scenario Comparison (COVID-19 vs Non COVID-19)
  9. Global mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA
      2. By Application Type
        1. COVID mRNA Application
          1. Commercialised Vaccine
            1. mRNA-1273
            2. BNT162b2
          2. Pipeline Vaccines
            1. CVnCoV
            2. LUNAR-COV19
            3. MRT5500
            4. DS-5670
        2. Non-COVID mRNA Application
          1. Immuno-Oncology
          2. Cardiology
          3. Endocrinology
          4. Haematology
          5. Other infectious & rare diseases
      3. By End Users
        1. Hospitals & healthcare Clinics
        2. Research Organisation & Institutions
        3. Others
      4. By Region
        1. North America
        2. South America
        3. Europe
        4. Asia-Pacific
        5. Middle East & Africa
      5. By Competitor
        1. Competition Characteristics
        2. Competitor Alignment in Competition Matrix
  10. North America mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
      2. By Application Type
      3. By End User
      4. By Country
        1. The US mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        2. Canada mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        3. Mexico mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
  11. South America mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
      2. By Application Type
      3. By End User
      4. By Country
        1. Brazil mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        2. Argentina mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
  12. Europe mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
      2. By Application Type
      3. By End User
      4. By Country
        1. The UK mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        2. Germany mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        3. France mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        4. Italy mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        5. Spain mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
  13. Asia-Pacific mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
      2. By Application Type
      3. By End User
      4. By Country
        1. China mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        2. India mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        3. Japan mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        4. South Korea mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        5. Australia mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
  14. Middle East & Africa mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
      2. By Application Type
      3. By End User
      4. By Country
        1. UAE mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        2. Saudi Arabia mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        3. South Africa mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
  15. Global mRNA Vaccines and Therapeutics Market Analysis Dynamics
    1. Growth Drivers
    2. Challenges
    3. Impact Analysis
  16. Global mRNA Vaccines and Therapeutics Market Key Strategic Imperatives for Success & Growth
  17. Competitive Benchmarking
    1. Competition Matrix
      1. Product Portfolio
      2. Target Markets
      3. Target Security Type
      4. Research & Development
      5. Strategic Alliances
      6. Strategic Initiatives
    2. Company Profiles (Business Description, Product Offering, Target Markets, Assets, Strategic Alliances or Partnerships, etc.)
      1. Arcturus Therapeutics Holdings Inc.
      2. BioNTech
      3. CureVac N.V.
      4. ethris GmbH
      5. Gennova Biopharmaceuticals Ltd
      6. GlaxoSmithKline plc
      7. Moderna
      8. Pantherna Therapeutics GmbH
      9. Pfizer
      10. Providence Therapeutics
      11. Providence Therapeutics
      12. Silence Therapeutics
      13. Translate Bio
      14. Versameb AG
      15. Verve Therapeutics, Inc.
  18. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Related Reports
Talk to our Consultant Talk to our Consultant
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization Request Customization